Metabolic Disorders Archives - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Metabolic Disorders

PTC acquires Censa: diversifying into metabolic disease

Rare disease-focused PTC Therapeutics has entered into an agreement to acquire Massachusetts-based Censa Pharmaceuticals. The deal centres around Censa’s lead product CNSA-001, an investigational therapy for rare metabolic diseases associated…